Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Cell Therapy Asia 2018
Conferences  \  Cell Therapy Asia 2018  \  Agenda  \  Hirofumi Suemori
RegisterLogin

Hirofumi Suemori's Biography


Hirofumi Suemori, Associate Professor, Laboratory of Embryonic Stem Cell Research, Institute for Frontier Life and Medical Sciences, Kyoto University

B.Sc. from Kyoto Univ. PhD from Nagoya Univ. 2000- Research Associate, Inst.Frontier Med Sci., Kyoto Univ. 2003-Associate Professor, Inst.Frontier Med Sci., Kyoto Univ. 2003: Derivation of the first hESC in Japan. 2016: start a project to derive clinical-grade hESC.

Hirofumi Suemori Image

Derivation of Clinical-Grade hESC in Japan

Thursday, 6 December 2018 at 11:30

Add to Calendar ▼2018-12-06 11:30:002018-12-06 12:30:00Europe/LondonDerivation of Clinical-Grade hESC in JapanCell Therapy Asia 2018 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com

After obtaining governmental permission to derive clinical-grade hESC lines in 2017, we have been trying to produce hESC in compliant with relevant regulations and guidelines. Progress of our project will be presented.

Add to Calendar ▼2018-12-06 00:00:002018-12-07 00:00:00Europe/LondonCell Therapy Asia 2018Cell Therapy Asia 2018 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors